Invention Grant
- Patent Title: Oxadiazole derivatives for the treatment of diabetes
- Patent Title (中): 用于治疗糖尿病的恶二唑衍生物
-
Application No.: US13059079Application Date: 2009-07-09
-
Publication No.: US08377975B2Publication Date: 2013-02-19
- Inventor: Markus Klein , Norbert Beier , Florian Lang
- Applicant: Markus Klein , Norbert Beier , Florian Lang
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
- Current Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102008038220 20080818
- International Application: PCT/EP2009/004992 WO 20090709
- International Announcement: WO2010/020305 WO 20100225
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D271/10
Abstract:
Novel oxadiazole derivatives of the formula (I), in which R, R′, Y, X1, X2 and X3 have the meanings indicated in claim 1, are kinase inhibitors and can be used for the treatment of diseases and conditions such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, in general in all types of fibroses, inflammatory processes, tumours and tumour diseases.
Public/Granted literature
- US20110139654A1 OXADIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES Public/Granted day:2011-06-16
Information query
